Concepedia

Katarina Mirjačić Martinović

KM

Statistics

Publications

17

Citations

585

H-Index

14

Active since

2007

Affiliations

Oncology Institute of Vojvodina(Current)

University of Kragujevac

University of Belgrade

GTx (United States)

Katarina Mirjačić Martinović is an author at Oncology Institute of Vojvodina specializing in immunology, oncology, and cancer immunology.

ORCID

Publications per year

2007–2023

17

Publications

17

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić et al. · Clinical & Experimental Metastasis · 2007 · 91 citations

, , +14

Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells

Gordana Konjević, Katarina Mirjačić Martinović, Vladimir Jurišić et al. · Biomarkers · 2009 · 73 citations

, , +17

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients

Katarina Mirjačić Martinović, Nada Babović, Radan Džodić et al. · Melanoma Research · 2014 · 56 citations

, , +16

Decreased CD161 activating and increased CD158a inhibitory receptor expression on NK cells underlies impaired NK cell cytotoxicity in patients with multiple myeloma

Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović et al. · Journal of Clinical Pathology · 2016 · 51 citations

, , +17

Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients

Katarina Mirjačić Martinović, Nada Babović, Radan Džodić et al. · Journal of Translational Medicine · 2015 · 47 citations · Full text

, , +17

1–5 of 17